Cargando…

Author Correction: Estimation of the timing of BAP1 mutation in uveal melanoma progression

Detalles Bibliográficos
Autores principales:	Uner, Ogul E., See, Thonnie Rose O., Szalai, Eszter, Grossniklaus, Hans E., Stålhammar, Gustav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371015/ https://www.ncbi.nlm.nih.gov/pubmed/34404859 http://dx.doi.org/10.1038/s41598-021-96113-0

Ejemplares similares

Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021)

Digital Image Analysis of BAP-1 Accurately Predicts Uveal Melanoma Metastasis
por: Stålhammar, Gustav, et al.
Publicado: (2019)

Density of PAS positive patterns in uveal melanoma: Correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis
por: Stålhammar, Gustav, et al.
Publicado: (2019)

Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression
por: Stålhammar, Gustav, et al.
Publicado: (2021)

Prediction of BAP1 Expression in Uveal Melanoma Using Densely-Connected Deep Classification Networks
por: Sun, Muyi, et al.
Publicado: (2019)

Animal Models of Uveal Melanoma
por: Uner, Ogul E., et al.
Publicado: (2022)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

Sex‐based differences in early and late uveal melanoma‐related mortality
por: Stålhammar, Gustav
Publicado: (2022)

An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome
por: Young, Kelly Z., et al.
Publicado: (2020)

Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma
por: Djulbegovic, Mak B., et al.
Publicado: (2022)

Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma
por: Ewens, K. G., et al.
Publicado: (2018)

Long-term relative survival in uveal melanoma: a systematic review and meta-analysis
por: Stålhammar, Gustav, et al.
Publicado: (2022)

Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma
por: Sabazade, Shiva, et al.
Publicado: (2021)

Opposite Roles of BAP1 in Overall Survival of Uveal Melanoma and Cutaneous Melanoma
por: Liu-Smith, Feng, et al.
Publicado: (2020)

Expression of immune checkpoint receptors Indoleamine 2,3‐dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma
por: Stålhammar, Gustav, et al.
Publicado: (2019)

Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma
por: Masoomian, Babak, et al.
Publicado: (2018)

Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma
por: Yen, Matthew, et al.
Publicado: (2018)

BAP1 methylation: a prognostic marker of uveal melanoma metastasis
por: Bakhoum, Mathieu F., et al.
Publicado: (2021)

Digital morphometry and cluster analysis identifies four types of melanocyte during uveal melanoma progression
por: Stålhammar, Gustav, et al.
Publicado: (2023)

Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma
por: Cole, Yasemin C., et al.
Publicado: (2022)

The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
por: Hagström, Anna, et al.
Publicado: (2022)

The prognostic implication of visual acuity at the time of uveal melanoma diagnosis
por: Asplund, Elin, et al.
Publicado: (2022)

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
por: Matatall, Katie A, et al.
Publicado: (2013)

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
por: Carbone, Michele, et al.
Publicado: (2012)

A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers
por: Aoude, Lauren G., et al.
Publicado: (2013)

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma
por: Amaria, Rodabe N., et al.
Publicado: (2023)

Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study
por: Kal Omar, Ruba, et al.
Publicado: (2023)

Editorial: Uveal melanoma: from lab bench to clinic – new therapeutic advances
por: D'Amico, Agata Grazia, et al.
Publicado: (2023)

Overrepresentation of human epidermal growth factor receptor 2 positive- and Luminal B breast cancer metastases in the eyes and orbit
por: Stålhammar, Gustav, et al.
Publicado: (2022)

Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
por: Figueiredo, Carlos R, et al.
Publicado: (2020)

Nuclear expression of BAP-1 in transvitreal incisional biopsies and subsequent enucleation of eyes with posterior choroidal melanoma
por: Herrspiegel, Christina, et al.
Publicado: (2021)

Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma
por: Farquhar, Neil, et al.
Publicado: (2017)

Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
por: Patterson, Andrew, et al.
Publicado: (2023)

A Prognostic Score for the Prediction of Local Treatment Failure in Plaque Brachytherapy of Uveal Melanoma
por: Kal Omar, Ruba, et al.
Publicado: (2022)

Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells
por: Qutob, Nouar, et al.
Publicado: (2019)

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2020)

Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome
por: Abbassi, Yasaman Arjmand, et al.
Publicado: (2022)

Author Correction: Telomere length and survival in primary cutaneous melanoma patients
por: Rachakonda, Sivaramakrishna, et al.
Publicado: (2018)

Author Correction: The incidence and clinical analysis of non‑melanoma skin cancer
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

Co‐occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence
por: Yu, Le, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_17covv1nr6m41tlm7ed2jd96m5